Sarepta Therapeutics, Inc. Human Resources Contracts & Agreements
79 Contracts & Agreements
- Bonus & Incentive Agreements (34 contracts)
- Change of Control Agreements (5)
- Compensation Agreements (1)
- Consulting Agreements (3)
- Employment Agreements (27)
- Separation Agreements (7)
- Severance Agreements (2)
- Amendment No. 1 to the Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Filed With SEC on June 7, 2024)
- Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Filed With SEC on May 1, 2024)
- Form of Stock Option Award Agreement under Sarepta Therapeutics, Inc. 2024 Employment Commencement Incentive Plan (Filed With SEC on May 1, 2024)
- Sarepta Therapeutics Inc.'s Policy for Recoupment of Incentive Compensation (Filed With SEC on February 28, 2024)
- Amendment No. 3 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 9, 2023)
- Amendment No. 2 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 3, 2022)
- Form of Performance-Based Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on May 4, 2022)
- Separation Agreement and General Release, signed November 15, 2021 between Sarepta Therapeutics, Inc. and Dr. Gilmore O'Neill (Filed With SEC on March 1, 2022)
- Separation and Consulting Agreement and General Release between David T. Howton Jr. and Sarepta Therapeutics, Inc (Filed With SEC on March 1, 2021)
- Separation Agreement and General Release between Sandesh Mahatme and Sarepta Therapeutics, Inc (Filed With SEC on August 5, 2020)
- Amendment No. 1 to the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on June 8, 2020)
- Amendment No. 2 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on February 21, 2020)
- Sub-Plan for Japan under the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on August 7, 2019)
- Sub-Plan for Japan under the Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 7, 2019)
- Form of Change in Control and Severance Agreement entered into between Sarepta Therapeutics, Inc. and each of Sandesh Mahatme, David Tyronne Howton, Jr. and Alexander Bo Cumbo (Filed With SEC on May 8, 2019)
- Form of Severance Letter Agreement entered into between Sarepta Therapeutics, Inc. and each of Sandesh Mahatme, David Tyronne Howton, Jr. and Alexander Bo Cumbo (Filed With SEC on May 8, 2019)
- Form of Stock Appreciation Right Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 31, 2018)
- Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 31, 2018)
- Form of Restricted Stock Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 31, 2018)
- Form of Stock Option Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on October 31, 2018)
- Amendment No. 2 to the Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on August 8, 2018)
- Form of Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2014 Employment Commencement Incentive Plan (Filed With SEC on August 8, 2018)
- Change in Control and Severance Agreement between Sarepta Therapeutics, Inc. and Gilmore ONeill, M.D., effective as of June 7, 2018 (Filed With SEC on August 8, 2018)
- Employment Agreement between Sarepta Therapeutics, Inc. and Gilmore ONeill, M.D., effective as of June 7, 2018 (Filed With SEC on August 8, 2018)
- Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan (Filed With SEC on August 8, 2018)
- General Release and Amendment to Separation Agreement between Sarepta Therapeutics, Inc. and Dr. Catherine Stehman-Breen dated April 12, 2018 (Filed With SEC on May 3, 2018)
- Form of Severance Letter Agreement entered between Sarepta Therapeutics, Inc. and each of Sandesh Mahatme, Alexander Bo Cumbo, David Tyronne Howton, Jr. and Shamim Ruff (Filed With SEC on March 1, 2018)
- Consulting Agreement dated August 17, 2017 by and between Sarepta Therapeutics, Inc. and Dr. Edward M. Kaye (Filed With SEC on November 1, 2017)
- SAREPTA THERAPEUTICS, INC. 2014 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN PERFORMANCE STOCK OPTION AWARD AGREEMENT (Filed With SEC on June 28, 2017)
- SAREPTA THERAPEUTICS, INC. 2014 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on June 28, 2017)
- AMENDMENT NO. 1 TO THE SAREPTA THERAPEUTICS, INC. 2014 EMPLOYMENT COMMENCEMENT INCENTIVE PLAN (Filed With SEC on June 28, 2017)
- SAREPTA THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on June 28, 2017)
- Sarepta Therapeutics, Inc. EMPLOYMENT AGREEMENT (Filed With SEC on June 28, 2017)
- SAREPTA THERAPEUTICS, INC. Amended and Restated 2011 EQUITY INCENTIVE PLAN STOCK APPRECIATION RIGHT AWARD AGREEMENT (STOCK SETTLED) (Filed With SEC on February 28, 2017)
- SAREPTA THERAPEUTICS, INC. 2011 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on February 28, 2017)
- SAREPTA THERAPEUTICS, INC. AMENDED AND RESTATED 2011 EQUITY INCENTIVE PLAN Restricted Stock Agreement (Filed With SEC on February 28, 2017)
- SAREPTA THERAPEUTICS, INC. Amended and Restated 2011 EQUITY INCENTIVE PLAN STOCK OPTION AWARD AGREEMENT (Filed With SEC on February 28, 2017)
- Sarepta Therapeutics, Inc. EMPLOYMENT AGREEMENT (Filed With SEC on November 7, 2016)
- AMENDED AND RESTATED SAREPTA THERAPEUTICS, INC. 2011 EQUITY INCENTIVE PLAN (as Amended and Restated on June 27, 2016) (Filed With SEC on July 1, 2016)
- SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 6, 2015)
